Epigenetic and Transcriptomic Pathways Underlying Animal Models of Cognitive and Psychiatric Disorders: A Scoping Review
Current Issues in Molecular Biology · 21.04.2026 · 48 (4) · 425
DOI: 10.3390/cimb48040425 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 21.04.2026. Verfasst von Jaishriram Rathored und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Central Research Laboratory and Molecular Diagnostics, Datta Meghe Institute of Higher Education & Research, Sawangi Meghe, Wardha 4420…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cognitive and psychiatric disorders are caused by a complex interplay between genetic predisposition, environmental exposures, and dynamic molecular regulation in the brain. Animal models provide a controlled environment for examining these mechanisms, and advances in transcriptome and epigenomic technologies have greatly expanded our knowledge of disease-relevant pathways.
Objective
This scoping review systematically maps and synthesizes the epigenetic and transcriptomic findings from the established animal models of four neuropsychiatric conditions—autism spectrum disorder (ASD), schizophrenia, depression, and Rett syndrome—drawing on a PRISMA-ScR-guided literature search. The review characterizes the breadth of evidence, identifies convergent and divergent molecular pathways, and highlights the translational gaps and therapeutic implications.
Methods
Research employing chromatin accessibility testing, genome-wide DNA methylation mapping, single-cell and bulk RNA sequencing, histone modification profiling, and multi-omics integration in mouse and other validated animal models was thoroughly reviewed. A quality appraisal of the primary experimental studies (n = 63) was performed using a modified CAMARADES checklist.
Results
Beyond generalized cellular stress responses, multi-omics analysis emphasizes the cell-type- and context-dependent nature of epigenetic changes in animal models, including isoform-specific histone modifications and model-dependent binding of HDAC/MeCP2 complexes to genes involved in synaptic plasticity. Single-cell RNA sequencing analyses have uniformly shown transcriptional changes in parvalbumin-positive (PV+) interneurons.
Conclusions
The specific convergence of epigenetic disruptions in neural circuits involved in synaptic structure and inhibitory function could play a role in the generation of neuropsychiatric phenotypes in animal models, highlighting the importance of circuit- and cell-type-specific epigenetics while pointing to potential therapeutic avenues.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Central Research Laboratory and Molecular Diagnostics, Datta Meghe Institute of Higher Education & Research, Sawangi Meghe, Wardha 442001, Maharashtra, India.
- Centre for Neural Development and Repair (CNDR), Lewis Katz School of Medicine, Temple University, 3500 N. Broad St., Philadelphia, PA 19140, USA.
ORCID-Profile: Jaishriram Rathored, Ajay Pal
Zitieren
APA
Rathored, J., Pal, A., & Sai Painkra, D. (2026). Epigenetic and Transcriptomic Pathways Underlying Animal Models of Cognitive and Psychiatric Disorders: A Scoping Review. Current Issues in Molecular Biology, 48(4), 425. https://doi.org/10.3390/cimb48040425
Vancouver
Rathored J, Pal A, Sai Painkra D. Epigenetic and Transcriptomic Pathways Underlying Animal Models of Cognitive and Psychiatric Disorders: A Scoping Review. Current Issues in Molecular Biology. 2026;48(4):425. doi:10.3390/cimb48040425
BibTeX
@article{Rathored2026,
author = {Rathored, Jaishriram and Pal, Ajay and Sai Painkra, Deepika},
title = {Epigenetic and Transcriptomic Pathways Underlying Animal Models of Cognitive and Psychiatric Disorders: A Scoping Review},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {4},
pages = {425},
doi = {10.3390/cimb48040425}
}
EUVIMED